Nabumetone Tablet
Product Images NDC 71335-1391

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 71335-1391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

This is a graph depicting Nabumetone Active Metabolite (BMNA) plasma concentrations at steady state following once-daily dosing of Nabumetone 1000 mg (n=31) and 2000 mg (n=12) over a period of time (in hours).*

FDA Label Image

Label Image (Lbl713351391)

This text appears to be a identification and comparison of a medication called "Relafen 500mg Tablet" manufactured by ScieGen Pharmaceuticals Inc. The packaging appears to have been done by Bryant Ranck Prepack, and the medication is contained in a package of 20 tablets with an expiry date of MM/YY. The NDC number is 7133513911. The prescription labels should be examined prior to use. The text instructs to keep the medication at room temperature, specifically 20°-25°C (68°-77°F). The medication should also be kept out of children's reach.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH CHgO.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.